Marvel Biosciences Corp (TSE:MRVL) has released an update.
Marvel Biosciences Corp. has granted incentive stock options for its directors and officers to purchase 1,475,000 common shares at $0.125 each, matching the closing price on the TSX Venture Exchange the day before the grant. These options are exercisable until July 2029, with a vesting schedule that allows for immediate access to a third, and the remainder over the next two years.
For further insights into TSE:MRVL stock, check out TipRanks’ Stock Analysis page.
